International Flavors & Fragran (IFF) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

International Flavors & Fragran

NYSE•Basic Materials•Specialty Chemicals

$84.91+0.51(0.01%)After hours

Market Cap

$21.65B

P/E

83.6x

P/S

2.2x

P/B

1.5x

International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and markets food, beverage, health and biosciences, scent, and complementary adjacent products in the United States, and internationally. It operates in through Taste, Food Ingredients, Health & Biosciences, and Scent segments. The Taste segment offers savory products such as soups, sauces, meat, fish, poultry, snacks; beverages consists of juice drinks, carbonated or flavored beverages, spirits; sweets comprising, bakery products, candy, cereal, chewing gum; and dairy products, such as yogurt, ice cream, cheese, and other products, as well as spices and seasoning ingredients for meat, food service, convenience, alternative protein and culinary products. The Food Ingredients segment provides natural, artificial, and plant-based specialty food ingredients; natural antioxidants and anti-microbials used for natural food preservation and shelf-life extension for beverages, cosmetic and healthcare products, pet food and feed additives; and savory solutions, such as spices, marinades, and mixtures, and inclusion products comprising combining flavorings with fruit, vegetables and other natural ingredients, as well as soy and pea protein with value-added formulations, emulsifiers and sweeteners. The Health & Biosciences segment offers enzymes, food cultures, probiotics and specialty ingredients for food and non-food applications, as well as engages in health, food biosciences, home and personal care, animal nutrition and grain processing businesses. The Scent segment creates fragrance compounds, and fragrance ingredients. International Flavors & Fragrances Inc. was incorporated in 1909 and is headquartered in New York, New York.

How this company scores

AverageMetricSide Score: 55/100

Strongest: Balance Sheet & Red Flags (19/25); weakest: Growth (11/25).

Profitability12/25

Growth11/25

Balance Sheet & Red Flags19/25

Cash & Earnings Quality13/25

Strengths

Rising earningsLow leverageProfit converts from growthImproving leverage

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 83.6x5y range 22.1x – 480.2x

Currently near its 12-quarter median.

P/S · 2.2x5y range 1.4x – 3.4x

Currently near its 20-quarter median.

P/B · 1.5x5y range 1.0x – 1.8x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Red Flag

The company posted negative operating margins in recent quarters — core operations are unprofitable.

Earnings Quality

Watch

FCF/Net Income has dropped below 0.7x in 3 quarters — monitor for earnings quality deterioration.

Price & Volume

Market Cap $21.65B

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $9.98B
Q. Revenue: $1.95B
TTM EBITDA: $1.70B
TTM Op. Income: $754.00M
Q. Op. Income: $158.00M
TTM Net Income: $259.00M
Q. Net Income: $50.00M
EPS: $0.2
Shares Out.: $255.00M

$9.98B in TTM revenue declined 11.7% YoY, reaching $1.95B last quarter. TTM EBITDA of $1.70B and TTM operating income of $754.00M show growth is flowing through to the bottom line. TTM net income of $259.00M means revenue is converting into profit. Across the last 8 quarters, TTM revenue has fallen for 6 consecutive quarters — a weakening trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 43.7%
EBITDA Margin: 19.2%
Op. Margin: 8.1%
Net Margin: 2.6%

Op. margin of 8.1% is up 0.9% YoY — cost efficiency is improving. Net margin at 2.6% and gross margin of 43.7% show how much of each revenue dollar survives to profit. Over the past year, operating margin is up 13% — a weakening trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 83.6x
P/S Ratio: 2.2x
P/B Ratio: 1.5x

At 83.6x P/E, the stock trades above typical market levels — the market expects above-average growth. P/S of 2.2x and P/B of 1.5x provide additional context. P/E sits above typical market levels while revenue growth is below 5%. Over the past year, P/E is up 0% — a weakening trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $25.15B
Cash: $569.00M
Long-Term Debt: $4.74B
Book Value: $13.98B
D/E Ratio: 0.3
Debt/EBITDA: 12.6

With $25.15B in assets and $4.74B in long-term debt, D/E is 0.3and book value is $13.98B — a conservative capital structure with a cushion to weather downturns. Across the last 8 quarters, debt/equity has risen for 3 consecutive quarters — a weakening trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $422.00M
TTM Free Cash Flow: $540.00M
FCF Margin: 5.4%
FCF / Net Income: 2.1

TTM FCF of $540.00M on $422.00M in operating cash flow. The FCF / Net Income ratio of 2.1x means free cash flow covers net income — earnings are backed by cash. Across the last 8 quarters, free cash flow has risen for 2 consecutive quarters — an improving trend.